Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Cilloniz Campos (Barcelona, Spain), C. Dominedò (Roma, Italy), A. Gabarrus (Barcelona, Spain), C. Garcia-Vidal (Barcelona, Spain), E. Moreno (Barcelona, Spain), C. Vargas (Barcelona, Spain), A. Torres (Barcelona, Spain). Methicillin-susceptible Staphylococcus aureus in Community-Acquired Pneumonia: Risk Factors and Outcomes. 4671

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant Staphylococcus aureus Isolates from Patients with Empyema Thoracis in Central Taiwan Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia in Portuguese Adults: A single-center retrospective study Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus in Mice Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Emerging macrolide-resistant mycoplasma pneumoniae in Thailand Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Screening for methicilin-resistant staphylococcus aureus colonization: A pulmonology department experience Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 Pseudomonas aeruginosa pneumonia in the community Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Clinical impact of a prediction score for drug-resistance in community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia Source: Eur Respir J 2009; 34: 1148-1158 Year: 2009 Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007 Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007